If you have been reading about GLP-1 receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-06-13. Numbers and descriptions here follow the published literature rather than marketing material.
Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.
Trial reports for this compound rely on a small set of repeated measures. Body weight is normally expressed as percent change from baseline at a fixed week, with absolute kilograms given secondarily. Glycemic endpoints include HbA1c, fasting glucose, and, in some protocols, continuous glucose monitoring summaries. Imaging endpoints such as MRI-derived proton density fat fraction quantify liver fat. Standardization matters because a percent change and a categorical responder analysis can tell different stories about the same dataset.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
| Property | Value | Notes |
|---|---|---|
| Trial design | Randomized, double-blind, placebo-controlled | Frequently includes dose-escalation arms |
| Weight endpoint | Percent change from baseline | Reported at a prespecified week |
| Liver fat endpoint | MRI proton density fat fraction | Non-invasive imaging measure |
| Body composition method | Dual-energy X-ray absorptiometry | Separates fat mass from lean mass |
| Common adverse events | Nausea, diarrhea, vomiting | Reported most often during dose escalation |
Stability studies examine how the molecule changes under defined conditions of temperature, humidity, and light exposure over time. Results are used to set storage recommendations and shelf-life limits. In practice, lyophilized peptide material is often stored at low temperatures to slow degradation, while reconstituted solutions are handled more carefully because they are generally less stable. Reported stability data apply to specific formulations and conditions, so extrapolation to other preparations requires caution.
Retatrutide is handled in laboratories mainly as a lyophilized solid for analytical and biochemical research. The peptide is typically supplied as a white to off-white powder and is reconstituted in appropriate solvents before use. Because peptide-based molecules are sensitive to temperature, moisture, and repeated freeze-thaw cycles, proper storage conditions affect both stability and measurement accuracy. Laboratories generally follow documented handling procedures to maintain the integrity of the material across experiments.
Identification and purity assessment rely on established analytical techniques. Reverse-phase high-performance liquid chromatography separates the compound from related impurities and degradation products. Mass spectrometry confirms molecular identity and detects modifications that change the expected mass. Additional methods such as amino acid analysis or capillary electrophoresis may be used for verification. Small differences in sample preparation can influence results, so procedures are usually controlled and documented in detail. Consistency between runs supports confidence in reported values.
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
Investigational peptide material is commonly distributed as a lyophilized powder in sealed vials. The solid form appears as a white to off-white cake or powder and is hygroscopic once opened. Peptides of this size are sensitive to moisture, repeated freeze-thaw cycles, and prolonged exposure to ambient light. Handling practices therefore emphasize desiccation, minimal vial opening, and cold storage. Working aliquots are often prepared to avoid repeatedly warming the bulk container.
Solid material is generally held at -20 °C or colder, while reconstituted solutions are kept at 2-8 °C and used within a short window. Buffers that maintain a slightly acidic to neutral pH tend to improve short-term peptide stability. Repeated warming and cooling of stock solutions promotes aggregation and should be avoided. Container closures should remain intact, since adsorption to some plastics can reduce the amount of peptide in solution.
The osmotic-controlled release oral delivery system (OROS) is an advanced controlled release oral drug delivery system in the form of a rigid tablet with a semi-permeable outer membrane and one or more small laser drilled holes in it. As the tablet passes through the body, water is absorbed through the semipermeable membrane via osmosis, and the resulting osmotic pressure is used to push the active drug through the laser drilled opening(s) in the tablet and into the gastrointestinal tract. OROS is a trademarked name owned by ALZA Corporation, which pioneered the use of osmotic pumps for oral drug delivery.
The report of this year-long inquiry, published in June 2004, found that the Mariam Appeal was undertaking charitable work (and so ought to have registered with the commission), but did not substantiate allegations that any funds had been misused. It emerged some years later that Galloway had appealed in a letter dated 24 April 2003 to Lord Goldsmith, the Attorney-General, to stop the investigation into the Mariam Appeal. According to a report in The Times, after the letter was released under the Freedom of Information Act, Galloway falsely asserted that the appeal "received no money from Iraq". A further Charity Commission Report published on 7 June 2007 found that the appeal had received funds from Fawaz Zureikat that originated from the Oil-for-Food Programme, and concluded that,
==== Gang crackdown ==== From 25 to 27 March 2022, gangs in El Salvador committed 87 homicides; 62 were committed on 26 March alone, the deadliest day in Salvadoran history since the end of the Salvadoran Civil War (1979–1992). Florida International University research director José Miguel Cruz attributed the killings to a breakdown in a secret truce between the government and the gangs, a truce that Bukele has denied. Cruz believed that the killings were a message from the gangs to the government for more concessions as a part of the secret truce.
=== Grigori === Father Grigori (voiced by Jim French) is an Eastern Orthodox Christian priest who appears throughout the Ravenholm chapter of Half-Life 2. He is the only human survivor encountered in Ravenholm. Father Grigori's model is based on video game art director Daniel Dociu. He speaks enthusiastically about "tending to his flock", i.e. dispatching the remaining zombie inhabitants of the city with a Winchester Model 1886 and homemade traps while offering them consolatory words. He helps Gordon Freeman intermittently in Ravenholm, giving him a shotgun, combat tips, and advice mingled with biblical quotations. Eventually, Grigori escorts Freeman through a cemetery infested with zombies to show him a hidden passage to the mines out of the haunted town. After waving Gordon off, Grigori continues fighting the hordes of enemies until he retreats into a nearby tomb, ignites a wall of fire around it and disappears, laughing maniacally. In the Half Life 2: 20th Anniversary documentary it is stated that Doug Woods thought of the idea in a design meeting as a "preacher with a shotgun". Grigori wields a Winchester Model 1886 rifle named Annabelle that can not be used by the player under ordinary circumstances.
== History == Behavioral endocrinology has roots in ethology and is also seen as a combination of endocrinology and psychology. Like ethology, behavioral endocrinology focuses on behavior on the level of the whole organism. The invention of radioimmunoassay techniques revolutionized behavioral endocrinology, allowing scientists to see and quantify hormones. The field historically resists reductionist thinking and focuses on the physiological aspects of behavior.
Sources: en.wikipedia.org
The driver, Nicolaas Fourie, and his two passengers promptly surrendered and were disarmed. After the media were allowed to photograph the badly injured prisoners, they were then executed at point-blank range by a Bophuthatswana policeman, Ontlametse Bernstein Menyatswe. These killings effectively spelt the end of white right-wing military opposition to democratic reforms. On 12 March 1994, Mangope was deposed as President of Bophuthatswana by the South African government and the Transitional Executive Council. South African Ambassador to Bophuthatswana, Prof. Tjaart van der Walt, was then appointed as the territory's new administrator.
=== Colors of lanthanide complexes === Superficially lanthanide complexes are similar to those of the transition metals in that some are colored. However, for the common Ln3+ ions (Ln = lanthanide) the colors are all pale, and hardly influenced by the nature of the ligand. The colors are due to 4f electron transitions. As the 4f orbitals in lanthanides are "buried" in the xenon core and shielded from the ligand by the 5s and 5p orbitals they are therefore not influenced by the ligands to any great extent leading to a much smaller crystal field splitting than in the transition metals. The absorption spectra of an Ln3+ ion approximates to that of the free ion where the electronic states are described by spin-orbit coupling. This contrasts to the transition metals where the ground state is split by the crystal field. Absorptions for Ln3+ are weak as electric dipole transitions are parity forbidden (Laporte forbidden) but can gain intensity due to the effect of a low-symmetry ligand field or mixing with higher electronic states (e.g. d orbitals). f-f absorption bands are extremely sharp which contrasts with those observed for transition metals which generally have broad bands. This can lead to extremely unusual effects, such as significant color changes under different forms of lighting.
==== Partially competitive ==== The mechanism of partially competitive inhibition is similar to that of non-competitive, except that the EIS complex has catalytic activity, which may be lower or even higher (partially competitive activation) than that of the enzyme–substrate (ES) complex. This inhibition typically displays a lower Vmax, but an unaffected Km value.
The district's arterial roads are laid out on a grid system of north–south and east–west, corresponding to the concession roads of the original township, laid out to facilitate the establishment of farming communities. Kingston Road and Danforth Avenue were laid out prior to surveying the township, and both run diagonally in a southwest–northeast direction across the south end of Scarborough. From north to south, the major east–west arterial roads are Steeles Avenue, Finch Avenue, Sheppard Avenue, Ellesmere Road, Lawrence Avenue, Eglinton Avenue and St. Clair Avenue. From west to east, the major north–south arterial roads are Victoria Park Avenue, Pharmacy Avenue, Warden Avenue, Birchmount Road, Kennedy Road, Midland Avenue, Brimley Road, McCowan Road, Bellamy Road North, Markham Road, Scarborough Golf Club Road, Neilson Road, Morningside Avenue, Meadowvale Road and Port Union Road. Kingston Road was formerly Ontario Highway 2, and was the main highway through the district until the building of Highway 401, which runs east–west across the district, with six to eight lanes in each direction. The short, minor freeway Highway 2A runs parallel to Lake Ontario in the eastern part of Scarborough.
March 7, 2016: Law on the rights of foreigners in France; foreign women victims of violence more easily obtain residence permits. March 14, 2016: Law on child protection. April 13, 2016: Law strengthening the fight against the prostitution system and supporting sex workers; creation of an "exit from prostitution" program. August 8, 2016: Law on labor, modernizing social dialogue, and securing career paths; internal regulations must prohibit sexist behavior; legislative creation of the High Council for Professional Equality. October 7, 2016: Law for a digital republic; creation of the offense of sexual privacy violation (including "revenge porn"). November 18, 2016: Law modernizing justice in the 21st century; divorce by mutual consent no longer requires a judge but must involve lawyers and a notary. December 2, 2016: Social Security Financing Law for 2017, establishing the Agency for the Recovery of Unpaid Child Support. January 27, 2017: Law on equality and citizenship, prioritizing women at risk of forced marriage for social housing. February 27, 2017: Law reforming criminal statute of limitations; extension of limitation periods for offenses such as: moral harassment; death, rape or sexual assault threats; domestic violence; sexual assaults other than rape; further extensions for crimes such as rape, mutilating or permanently disabling domestic violence, murder, abduction, and imprisonment. March 20, 2017: Law extending the offense of obstructing abortion to new online practices (e.g., hindering access to information or the procedure itself).
Sources: en.wikipedia.org
In both meetings, according to him, "the good relations between Brazil and the Holy See and the harmonious collaboration between Church and State in favour of the promotion of moral values and the common good" were highlighted.
== Awards and honors == 1990 - Robert J. and Claire Pasarow Foundation Medical Research Award 1990 - American Association for Cancer Research - G.H.A. Clowes Memorial Award Archived 2017-10-24 at the Wayback Machine 1991 - Honorary doctorate in medicine from Lund University, Sweden 1995 - Nobel Fellow at the Karolinska Institutet in Stockholm 1997 - Gairdner Foundation International Award 1998 - Jacobaeus International Prize 2003 - Jubilee Lecturer, Biochemical Society 2005 - Japan Prize in Cell Biology 2012 - Thomson Reuters Citation Laureate Knight of the Order of the White Rose of Finland Commander of the Order of the Lion of Finland 2022 - Albert Lasker Award for Basic Medical Research. 2023 - Fellow of the American Association for Cancer Research. Member of National Academy of Sciences National Academy of Medicine American Academy of Arts and Sciences European Molecular Biology Organization
== External links == "Opioid Receptors: μ". The International Union of Basic and Clinical Pharmacology, The British Pharmacological Society, The University of Edinburgh. International Union of Basic and Clinical Pharmacology. mu+Opioid+Receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Human OPRM1 genome location and OPRM1 gene details page in the UCSC Genome Browser.
=== 7 May === Mikhail Razvozhayev, the Russian-installed governor of Crimea, claimed that Russian forces stopped a Ukrainian drone attack using air defence and electronic warfare, downing three of the drones without property damage or casualties.
Sources: en.wikipedia.org
A responder analysis counts participants who cross a threshold, such as five or ten percent weight loss. It complements average percent change by showing how widely results are distributed. The two measures can diverge when a subset of participants loses a large amount.
Mechanistic measures such as energy expenditure and liver fat change come from small substudies and should be read as preliminary. Long-term clinical outcomes are not yet available. Average weight loss figures are better supported than explanations for how the loss is achieved.
Endpoints reported at different weeks, in different baseline BMI ranges, or under different dose-escalation schedules are not directly comparable. Studies in type 2 diabetes often show smaller weight changes than studies in obesity without diabetes. Reporting the population alongside the number keeps comparisons honest.
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.